Label: AGE DEFYING HYDRATING SUNSCREEN SPF 30- avobenzone octinoxate octisalate oxybenzone homosalate octocrylene lotion

  • Category: HUMAN OTC DRUG LABEL

Drug Label Information

Updated October 5, 2023

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    ACTIVE INGREDIENTS:

    AVOBENZONE 3%, HOMOSALATE 7%, OCTINOXATE 7.5%, OCTISALATE 5%, OCTOCRYLENE 3%, OXYBENZONE 6%

  • PURPOSE

    PURPOSE:

    SUNSCREEN

  • INDICATIONS & USAGE

    USES:

    MULTI-ACTION FORMULA PROVIDES FULL-SPECTRUM UV AND ENVIRONMENTAL PROTECTION, WHILE RESTORING CRITICAL MOISTURE AND SKIN'S TIGHTNESS.

  • WARNINGS

    WARNINGS:

    FOR EXTERNAL USE ONLY.

  • KEEP OUT OF REACH OF CHILDREN

    KEEP OUT OF REACH OF CHILDREN.

  • OTHER SAFETY INFORMATION

    AVOID CONTACT WITH  EYES. IF CONTACT OCCURS, RINSE EYES THOROUGHLY WITH WATER.

  • STOP USE

    IF IRRITATION DEVELOPS, DISCONTINUE USE.

  • DOSAGE & ADMINISTRATION

    DIRECTIONS:

    APPLY AS LAST STEP IN MORNING ROUTINE OR BEFORE SUN EXPOSURE. REAPPLY AS NEEDED AFTER SWIMMING, PERSPIRING, OR TOWEL DRYING. AVOID APPLICATION NEAR EYE AREA.

  • INACTIVE INGREDIENT

    WATER, TAPIOCA STARCH, SD ALCOHOL 40, C12-15 ALKYL BENZOATE, DIPROPYLENE GLYCOL DIBENZOATE, PPG-15 STEARYL ETHER BENZOATE, BUTYLOCTYL SALICYLATE, CYCLOMETHICONE, PEG/PPG-18/18 DIMETHICONE, SILICA, VP/HEXADECENE COPOLYMER, ALOE BARBADENSIS LEAF JUICE, ALGAE EXTRACT, PANTHENOL, TOCOPHERYL ACETATE, TOCOPHEROL, DIMETHICONE, POLYSORBATE 80, ISOSTEARIC ACID, TRIETHANOLAMINE, TETRASODIUM EDTA, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, PHENOXYETHANOL, CAPRYL GLYCOL, ETHYLHEXYLGLYCERIN, HEXYLENE GLYCOL.

  • QUESTIONS

    QUESTIONS? +1-760-268-0047

  • PRINCIPAL DISPLAY PANEL

    SKIN AUTHORITY

    AGE DEFYING HYDRATING SUNSCREEN

    150 ML / 5.1 FL OZ

    51136(revA)150ml-AgeDefyingHydratingSunscreen


  • INGREDIENTS AND APPEARANCE
    AGE DEFYING HYDRATING SUNSCREEN  SPF 30
    avobenzone octinoxate octisalate oxybenzone homosalate octocrylene lotion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:46007-201
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE3 g  in 100 mL
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE7.5 g  in 100 mL
    OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE5 g  in 100 mL
    OXYBENZONE (UNII: 95OOS7VE0Y) (OXYBENZONE - UNII:95OOS7VE0Y) OXYBENZONE6 g  in 100 mL
    HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE7 g  in 100 mL
    OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE3 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    STARCH, TAPIOCA (UNII: 24SC3U704I)  
    ALCOHOL (UNII: 3K9958V90M)  
    ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
    DIPROPYLENE GLYCOL DIBENZOATE (UNII: 6OA5ZDY41O)  
    PPG-15 STEARYL ETHER BENZOATE (UNII: 80D2J6361M)  
    BUTYLOCTYL SALICYLATE (UNII: 2EH13UN8D3)  
    CYCLOMETHICONE (UNII: NMQ347994Z)  
    PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    COPOVIDONE K25-31 (UNII: D9C330MD8B)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    FUCUS VESICULOSUS (UNII: 535G2ABX9M)  
    PANTHENOL (UNII: WV9CM0O67Z)  
    ALPHA-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    TOCOPHEROL (UNII: R0ZB2556P8)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    ISOSTEARIC ACID (UNII: X33R8U0062)  
    TROLAMINE (UNII: 9O3K93S3TK)  
    EDETATE SODIUM (UNII: MP1J8420LU)  
    CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
    HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:46007-201-25150 mL in 1 TUBE; Type 0: Not a Combination Product04/19/2012
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02004/19/2012
    Labeler - Skin Authority LLC (136549396)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!